Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3

被引:46
作者
Kerr, AR [1 ]
Paterson, GK [1 ]
Riboldi-Tunnicliffe, A [1 ]
Mitchell, TJ [1 ]
机构
[1] Univ Glasgow, Div Infect & Immun, IBLS, Glasgow G12 8QQ, Lanark, Scotland
基金
英国惠康基金;
关键词
D O I
10.1128/IAI.73.7.4245-4252.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement is known to be involved in protection against systemic infection with Streptococcus pneumoniae. However, less is known about effects of complement within the lungs during pneumococcal pneumonia. By intranasally infecting transgenic mice unable to express complement C3, we investigated the role of complement in pulmonary defenses against S. pneumoniae. It was demonstrated that within the lungs, there is a requirement for C3 during the initial hours of infection. It was found that within I h of infection, bacterial loads decreased within lung airways of control mice as C3 protein increased. The lack of C3 resulted in the inability to control growth of wild-type or attenuated pneumococci within the lungs and bloodstream, resulting in an overwhelming inflammatory response and shorter survival times. Our results show that during the initial hours of infection with S. pneumoniae, C3 is protective within the lungs and subsequently plays an important role systemically.
引用
收藏
页码:4245 / 4252
页数:8
相关论文
共 42 条
[1]   Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats [J].
Alcantara, RB ;
Preheim, LC ;
Gentry, MJ .
INFECTION AND IMMUNITY, 1999, 67 (06) :2862-2866
[2]   Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia [J].
Alcantara, RB ;
Preheim, LC ;
Gentry-Nielsen, MJ .
INFECTION AND IMMUNITY, 2001, 69 (06) :3569-3575
[3]  
Alper C. A., 1970, NEW ENGL J MED, V282, P350
[4]   DEGRADATION OF C3 BY STREPTOCOCCUS-PNEUMONIAE [J].
ANGEL, CS ;
RUZEK, M ;
HOSTETTER, MK .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :600-608
[5]   Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice [J].
Bergeron, Y ;
Ouellet, N ;
Deslauriers, AM ;
Simard, M ;
Olivier, M ;
Bergeron, MG .
INFECTION AND IMMUNITY, 1998, 66 (03) :912-922
[6]   ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract [J].
Blue, CE ;
Paterson, GK ;
Kerr, AR ;
Bergé, M ;
Claverys, JP ;
Mitchell, TJ .
INFECTION AND IMMUNITY, 2003, 71 (09) :4925-4935
[7]   The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice [J].
Brown, JS ;
Hussell, T ;
Gilliland, SM ;
Holden, DW ;
Paton, JC ;
Ehrenstein, MR ;
Walport, MJ ;
Botto, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) :16969-16974
[8]   Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA [J].
Circolo, A ;
Garnier, G ;
Fukuda, W ;
Wang, XF ;
Hidvegi, T ;
Szalai, AJ ;
Briles, DE ;
Volanakis, JE ;
Wetsel, RA ;
Colten, HR .
IMMUNOPHARMACOLOGY, 1999, 42 (1-3) :135-149
[9]  
CIRCOLO A, 1997, COMPLEMENT PRACTICAL, P199
[10]   COMPLEMENT BIOSYNTHESIS BY HUMAN BRONCHOALVEOLAR MACROPHAGES [J].
COLE, FS ;
MATTHEWS, WJ ;
ROSSING, TH ;
GASH, DJ ;
LICHTENBERG, NA ;
PENNINGTON, JE .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1983, 27 (02) :153-159